课题基金 / 基金详情

Diverse Effects of a Stress-Related Ligand, Corticotropin-Releasing Factor, in Non-Human Primates

Diverse Effects of a Stress-Related Ligand, Corticotropin-Releasing Factor, in Non-Human Primates
压力相关配体促肾上腺皮质激素释放因子对非人类灵长类动物的多种影响
批准号:
9751235
负责人:
MEI-CHUAN KO
金额:
$19.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2021-07-31

项目摘要

项目成果

MEI-CHUAN KO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Corticotropin-releasing factor (CRF) is considered as a key mediator for individuals responding to stress. However, there have been very few reports on the effects of central CRF in primates. We propose to investigate the effects of intracisternally administered CRF in adult rhesus monkeys over a wide dose range by using diverse behavioral and physiological assays. In particular, these monkey assays have been established specifically to reflect the sensory processing for regulating pain and itch, neuroendocrine (ACTH and cortisol release), autonomic (respiration and cardiovascular activities), and behavioral (depressive-like and anxiety-like behavior) responses. In the first aim of this proposal, we will establish distinct analgeic profiles of central CRF versus β-endorphin and clarify the receptor mechanisms underlying analgesic effects of CRF and β-endorphin. In the second aim, several assays will be conducted to provide a broad repertoire of neuroendocrine, autonomic, and behavioral responses elicited by central CRF in monkeys. Our unique set of physiological and behavioral assays in awake, behaving rhesus monkeys implanted with catheters for intracisternal delivery of neuropeptides, in combination with receptor-selective antagonists, will provide valuable functional evidence of central CRF for modulating diverse physiological functions and improve our understanding of neuropeptides involved in stress-induced analgesia in primates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Buprenorphine analogs for the treatment of opioid abuse
Buprenorphine analogs for the treatment of opioid abuse
Buprenorphine analogs for the treatment of opioid abuse
Effects of a G protein-biased mu opioid receptor agonist PZM21 in primates
海外基金